Skip to main content
Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · IEX Real-Time Price · USD
2.340
0.00 (0.00%)
At close: May 2, 2024, 4:00 PM
2.290
-0.050 (-2.14%)
After-hours: May 2, 2024, 4:04 PM EDT

Oramed Pharmaceuticals Revenue

In the year 2023, Oramed Pharmaceuticals had annual revenue of $1.34M, a decrease of -50.43%.

Revenue (ttm)
$1.34M
Revenue Growth
-50.43%
P/S Ratio
70.76
Revenue / Employee
$103,077
Employees
13
Market Cap
94.81M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.34M-1.36M-50.43%
Dec 31, 20222.70M--
Aug 31, 20212.70M-7.00K-0.26%
Aug 31, 20202.71M7.00K0.26%
Aug 31, 20192.70M254.00K10.37%
Aug 31, 20182.45M-7.00K-0.29%
Aug 31, 20172.46M1.82M283.15%
Aug 31, 2016641.00K--
Aug 31, 20150--
Aug 31, 20140--
Aug 31, 20130--
Aug 31, 20120--
Aug 31, 20110--
Aug 31, 20100--
Aug 31, 20090--
Aug 31, 20080--
Aug 31, 20070--
Aug 31, 20060--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
111, Inc. 2.11B
Assertio Holdings 152.07M
ProPhase Labs 44.38M
Eton Pharmaceuticals 32.64M
BrainsWay 31.79M
BioXcel Therapeutics 1.38M
Genelux 170.00K
Revenue Rankings

ORMP News

More News